- Home
- ZLAB vs FBRT Comparison
ZLAB vs FBRT Comparison
Compare ZLAB & FBRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZLAB | FBRT |
|---|---|---|
| Founded | 2013 | 2012 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 695.9M |
| IPO Year | 2017 | 2012 |
Fundamental Metrics
Financial Performance| Metric | ZLAB | FBRT |
|---|---|---|
| Price | $25.10 | $6.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $49.60 | $11.50 |
| AVG Volume (30 Days) | 755.7K | ★ 2.0M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 15.83% |
| EPS Growth | ★ 38.46 | N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | ★ $460,156,000.00 | $270,071,000.00 |
| Revenue This Year | $9.75 | $12.34 |
| Revenue Next Year | $26.03 | $4.95 |
| P/E Ratio | ★ N/A | $36.84 |
| Revenue Growth | 15.33 | ★ 28.33 |
| 52 Week Low | $15.96 | $6.83 |
| 52 Week High | $34.72 | $11.20 |
Technical Indicators
Market Signals| Indicator | ZLAB | FBRT |
|---|---|---|
| Relative Strength Index (RSI) | 49.96 | 27.86 |
| Support Level | $24.81 | N/A |
| Resistance Level | $25.28 | $9.38 |
| Average True Range (ATR) | 0.77 | 0.28 |
| MACD | -0.14 | -0.10 |
| Stochastic Oscillator | 41.43 | 7.76 |
Price Performance
Historical ComparisonAbout ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
About FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. The Company's operations are organized into two business units: (i) Commercial Real Estate Financing, and (ii) Agency Business. Its four reporting segments are as follows: The real estate debt business, The Agency Business, The commercial real estate conduit business, and The real estate owned business.